HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements.

Abstract
From March to April 2006, an outbreak of mumps occurred in Gyeonggi, Korea. The aim of this study was to describe and discriminate between primary and secondary vaccine failure in a highly vaccinated population for mumps using IgG avidity testing. Fifteen clinical mumps cases occurred among 41 students. Among these 15 patients, 11 vaccinated patients were considered secondary vaccine failures with high IgG titers and a high avidity index (AI, > or =32%); an unvaccinated patient was considered to have primary infection with high IgG titers and low AI, and three vaccinated patients were considered as other infections with low IgG titers and low AI. Among 26 unaffected students, 5 vaccinated patients were retrospectively diagnosed as sub-clinical infection with high IgG titers and high AI; the remaining students had low IgG titers and low AI except for one previously infected student. The results of this study show that secondary vaccine failure played an important role in this mumps outbreak. Therefore, booster immunization for mumps should be considered in immunized adolescents to prevent further outbreaks.
AuthorsDae Won Park, Myung-Hyun Nam, Jung Yeon Kim, Hee Jung Kim, Jang Wook Sohn, Yunjung Cho, Ki-Joon Song, Min Ja Kim
JournalVaccine (Vaccine) Vol. 25 Issue 24 Pg. 4665-70 (Jun 11 2007) ISSN: 0264-410X [Print] Netherlands
PMID17498856 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Mumps Vaccine
Topics
  • Adolescent
  • Antibodies, Viral (blood, immunology)
  • Antibody Affinity
  • Disease Outbreaks
  • Humans
  • Immunoglobulin G (blood)
  • Korea
  • Male
  • Mumps (epidemiology, immunology)
  • Mumps Vaccine (immunology)
  • Mumps virus (immunology)
  • Students

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: